Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 07 2018
accepted: 23 01 2019
pubmed: 6 3 2019
medline: 20 4 2019
entrez: 6 3 2019
Statut: ppublish

Résumé

Cancer genomes are frequently characterized by numerical and structural chromosomal abnormalities. Here we integrated a centromere-specific inactivation approach with selection for a conditionally essential gene, a strategy termed CEN-SELECT, to systematically interrogate the structural landscape of mis-segregated chromosomes. We show that single-chromosome mis-segregation into a micronucleus can directly trigger a broad spectrum of genomic rearrangement types. Cytogenetic profiling revealed that mis-segregated chromosomes exhibit 120-fold-higher susceptibility to developing seven major categories of structural aberrations, including translocations, insertions, deletions, and complex reassembly through chromothripsis coupled to classical non-homologous end joining. Whole-genome sequencing of clonally propagated rearrangements identified random patterns of clustered breakpoints with copy-number alterations resulting in interspersed gene deletions and extrachromosomal DNA amplification events. We conclude that individual chromosome segregation errors during mitotic cell division are sufficient to drive extensive structural variations that recapitulate genomic features commonly associated with human disease.

Identifiants

pubmed: 30833795
doi: 10.1038/s41588-019-0360-8
pii: 10.1038/s41588-019-0360-8
pmc: PMC6441390
mid: NIHMS1519498
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

705-715

Subventions

Organisme : NCI NIH HHS
ID : K99 CA218871
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS047101
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA218871
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM122476
Pays : United States

Références

DNA Repair (Amst). 2009 Oct 2;8(10):1225-34
pubmed: 19683478
Cell. 2013 Jul 3;154(1):47-60
pubmed: 23827674
Mol Syst Biol. 2015 Sep 28;11(9):828
pubmed: 26415501
Nat Genet. 2012 Mar 04;44(4):390-7, S1
pubmed: 22388000
Elife. 2013 Apr 16;2:e00534
pubmed: 23599896
Cancer Cell. 2014 Nov 10;26(5):653-67
pubmed: 25517748
Cell Rep. 2018 Apr 3;23(1):227-238.e3
pubmed: 29617662
Cell. 2015 Dec 17;163(7):1641-54
pubmed: 26687355
Nature. 2009 Dec 24;462(7276):1005-10
pubmed: 20033038
Nat Genet. 2008 Jun;40(6):722-9
pubmed: 18438408
Nat Genet. 2018 Oct;50(10):1388-1398
pubmed: 30202056
J Cell Biol. 2000 Dec 25;151(7):1381-90
pubmed: 11134068
Nat Genet. 2017 Jul;49(7):1005-1014
pubmed: 28504702
Nature. 2000 May 25;405(6785):473-7
pubmed: 10839544
Nat Rev Genet. 2016 Apr;17(4):224-38
pubmed: 26924765
Nat Genet. 2017 Jan;49(1):36-45
pubmed: 27841880
Nature. 2014 Apr 3;508(7494):98-102
pubmed: 24670643
Nat Genet. 2011 Sep 04;43(10):964-968
pubmed: 21892161
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nature. 1973 Jun 1;243(5405):290-3
pubmed: 4126434
Cell. 2012 May 25;149(5):979-93
pubmed: 22608084
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Nature. 2003 Jun 19;423(6942):825-37
pubmed: 12815422
Cell Rep. 2012 Jun 28;1(6):648-55
pubmed: 22813740
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.9.1-15.9.17
pubmed: 27930809
Nature. 1982 Dec 23;300(5894):765-7
pubmed: 6960256
Cell. 2017 Feb 23;168(5):830-842.e7
pubmed: 28235197
Genomics. 1990 Oct;8(2):279-85
pubmed: 1979050
Genome Res. 2015 Jul;25(7):937-47
pubmed: 26070663
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Hum Mol Genet. 2011 May 15;20(10):1916-24
pubmed: 21349919
Cell. 2005 Feb 25;120(4):497-512
pubmed: 15734682
Cell Rep. 2017 Jun 20;19(12):2423-2431
pubmed: 28636931
Science. 2018 Aug 31;361(6405):
pubmed: 30166462
Methods Mol Biol. 2013;931:111-22
pubmed: 23027000
Science. 2016 Mar 25;351(6280):1454-1458
pubmed: 26940867
Nature. 2000 May 25;405(6785):477-82
pubmed: 10839545
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Nat Commun. 2017 Nov 6;8(1):1326
pubmed: 29109544
J Natl Cancer Inst. 1968 Jan;40(1):165-79
pubmed: 5635016
Cell. 2011 Jan 7;144(1):27-40
pubmed: 21215367
Blut. 1962 Apr;8:65-6
pubmed: 14480647
Science. 2011 Sep 30;333(6051):1895-8
pubmed: 21960636
Nat Commun. 2017 Jun 23;8:15936
pubmed: 28643781
Cell Cycle. 2017 Jul 3;16(13):1252-1258
pubmed: 28650219
Nat Genet. 2016 Feb;48(2):176-82
pubmed: 26656844
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7720-5
pubmed: 23610439
Cell. 2013 May 9;153(4):919-29
pubmed: 23663786
Nat Genet. 1999 Dec;23(4):429-32
pubmed: 10581029
J Cell Biol. 1989 Nov;109(5):1963-73
pubmed: 2808515
Cell. 2013 Apr 25;153(3):666-77
pubmed: 23622249
Trends Cell Biol. 2017 Dec;27(12):917-930
pubmed: 28899600
J Cell Biol. 2007 Aug 13;178(4):595-610
pubmed: 17698605
Dev Cell. 2017 Jun 19;41(6):638-651.e5
pubmed: 28633018
Nature. 2018 Jan 11;553(7687):171-177
pubmed: 29323295
J Cell Sci. 2018 Jul 9;131(13):
pubmed: 29930083
Nature. 2017 Mar 2;543(7643):122-125
pubmed: 28178237
Nat Cell Biol. 2017 Jan;19(1):68-75
pubmed: 27918550
J Cell Biol. 2010 Jul 12;190(1):73-87
pubmed: 20624901
Nat Methods. 2009 Dec;6(12):917-22
pubmed: 19915560
Nat Genet. 2018 May;50(5):708-717
pubmed: 29686388
Nature. 2017 Nov 30;551(7682):590-595
pubmed: 29168504
Methods Cell Biol. 1991;36:581-605
pubmed: 1839804
Nature. 2014 Jul 24;511(7510):428-34
pubmed: 25043047
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):E3350-7
pubmed: 23150568
Cell. 2018 Apr 19;173(3):611-623.e17
pubmed: 29656891
Nature. 2016 Oct 20;538(7625):378-382
pubmed: 27732578
Mol Cell Biol. 2001 Mar;21(5):1719-29
pubmed: 11238909
Cell. 1985 May;41(1):165-75
pubmed: 3888406
Annu Rev Genet. 2015;49:183-211
pubmed: 26442848
Nature. 2018 Sep;561(7724):551-555
pubmed: 30232450
Nature. 2012 Jan 18;482(7383):53-8
pubmed: 22258507
Cell. 2012 Jan 20;148(1-2):59-71
pubmed: 22265402
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310
J Biol Chem. 2001 Nov 9;276(45):42462-7
pubmed: 11571274
Cell. 2009 Dec 11;139(6):1069-83
pubmed: 19962179

Auteurs

Peter Ly (P)

Ludwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA. peter.ly@utsouthwestern.edu.
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. peter.ly@utsouthwestern.edu.

Simon F Brunner (SF)

Wellcome Sanger Institute, Hinxton, UK.

Ofer Shoshani (O)

Ludwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA.

Dong Hyun Kim (DH)

Ludwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA.

Weijie Lan (W)

Ludwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA.

Tatyana Pyntikova (T)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.

Adrienne M Flanagan (AM)

University College London Cancer Institute, London, UK.
Department of Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK.

Sam Behjati (S)

Wellcome Sanger Institute, Hinxton, UK.
Department of Paediatrics, University of Cambridge, Cambridge, UK.

David C Page (DC)

Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Howard Hughes Medical Institute, Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.

Peter J Campbell (PJ)

Wellcome Sanger Institute, Hinxton, UK.

Don W Cleveland (DW)

Ludwig Institute for Cancer Research, Department of Cellular and Molecular Medicine, University of California San Diego School of Medicine, La Jolla, CA, USA. dcleveland@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH